Grant: Operating Grant
University of Calgary
$677,877.00
Investigation of parasite drug metabolism as a mechanism of anthelmintic resistance and the identification of novel resistance genes.
EF 2010-11
Résumé
Parasitic worms infect over a billion people worldwide and are a major cause of suffering in the developing world. As with other types of infectious disease, parasites are developing resistance to the few available drugs. We need to understand the mechanisms by which parasites become resistant to drugs in order to diagnose, treat and manage the problem. This project will investigate the processes by which parasites modulate the activity of drugs and become resistant to them. The identification of the molecules involved is an important step in the development of sensitive and accurate tests for the diagnosis of resistance. It may also allow the design of new pharmaceutical agents which block these processes which would provide new powerful approaches to the treatment of drug resistant parasites.
Programme
Operating Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
210810
Name
Gilleard John S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Pharmaceutical Sciences
Projecttitle
Investigation of parasite drug metabolism as a mechanism of anthelmintic resistance and the identification of novel resistance genes.
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$677,877
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Anthelmintics; Genomics; Hplc-Ms; Nematodes; Parasites; Xenobiotic Responses
Abstract
Parasitic worms infect over a billion people worldwide and are a major cause of suffering in the developing world. As with other types of infectious disease, parasites are developing resistance to the few available drugs. We need to understand the mechanisms by which parasites become resistant to drugs in order to diagnose, treat and manage the problem. This project will investigate the processes by which parasites modulate the activity of drugs and become resistant to them. The identification of the molecules involved is an important step in the development of sensitive and accurate tests for the diagnosis of resistance. It may also allow the design of new pharmaceutical agents which block these processes which would provide new powerful approaches to the treatment of drug resistant parasites.
Competitiondate
201009
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Gilleard, John S
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $677,877~ $0~